{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T17:20:24Z","timestamp":1695403224263},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.8278","type":"journal-article","created":{"date-parts":[[2013,7,14]],"date-time":"2013-07-14T23:02:02Z","timestamp":1373842922000},"page":"1599-1603","source":"Crossref","is-referenced-by-count":5,"title":["Von Hippel Lindau Disease with Colon Adenocarcinoma, Renal Cell Carcinoma and Adrenal Pheochromocytoma"],"prefix":"10.2169","volume":"52","author":[{"given":"Laura","family":"Zinnamosca","sequence":"first","affiliation":[{"name":"Department Unit of Secondary Hypertension, Department of Internal Medicine and Medical Specialities, \"Sapienza\" University of Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Laudisi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Medical Oncology Unit, University of Rome \"Tor Vergata\", Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Petramala","sequence":"additional","affiliation":[{"name":"Department Unit of Secondary Hypertension, Department of Internal Medicine and Medical Specialities, \"Sapienza\" University of Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Marinelli","sequence":"additional","affiliation":[{"name":"Department Unit of Secondary Hypertension, Department of Internal Medicine and Medical Specialities, \"Sapienza\" University of Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Roselli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Medical Oncology Unit, University of Rome \"Tor Vergata\", Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Vitolo","sequence":"additional","affiliation":[{"name":"Department of Surgery, \"Sapienza\" University of Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Montesani","sequence":"additional","affiliation":[{"name":"Department of Surgery, \"Sapienza\" University of Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Letizia","sequence":"additional","affiliation":[{"name":"Department Unit of Secondary Hypertension, Department of Internal Medicine and Medical Specialities, \"Sapienza\" University of Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Woodward ER, Maher ER. Von Hippel-Lindau disease and endocrine tumour susceptibility. Endocr Relat Cancer 13: 415-425, 2006.","DOI":"10.1677\/erc.1.00683"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet 361: 2059-2067, 2003.","DOI":"10.1016\/S0140-6736(03)13643-4"},{"key":"3","unstructured":"3. Maher ER, Iselius L, Yates JR, et al. Von Hippel-Lindau disease: a genetic study. J Med Genet 28: 443-447, 1991."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490, 1998.","DOI":"10.1038\/28867"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sano T, Horiguchi H. Von Hippel-Lindau disease. Microsc Res Tech 60: 159-164, 2003.","DOI":"10.1002\/jemt.10253"},{"key":"6","unstructured":"6. Richard S, French VHL Study Group. von Hippel-Lindau disease: recent advances and therapeutic perspectives. Expert Rev Anticancer Ther 3: 215-233, 2003."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 90: 1039-1071, 1998.","DOI":"10.1093\/jnci\/90.14.1039"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Maher ER, Kaelin WG Jr. von Hippel-Lindau disease. Medicine (Baltimore) 76: 381-391, 1997.","DOI":"10.1097\/00005792-199711000-00001"},{"key":"9","unstructured":"9. Capra F, Scintu F, Zorcolo L, Marongiu L, Casula G. Synchronous colorectal and renal carcinomas. Is it a definite clinical entity? Chir Ital 55: 903-906, 2003."},{"key":"10","unstructured":"10. Halak M, Hazzan D, Kovacs Z, Shiloni E. Synchronous colorectal and renal carcinomas: a noteworthy clinical entity. Report of five cases. Dis Colon Rectum 43: 1314-1315, 2000."},{"key":"11","unstructured":"11. Lynch HT, Lemon SJ, Karr B, et al. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications. Cancer Epidemiol Biomarkers Prev 6: 987-991, 1997."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol 22: 4991-5004, 2004.","DOI":"10.1200\/JCO.2004.05.061"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zhuang Z, Emmert-Buck MR, Roth MJ, et al. Von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens. Hum Patol 27: 152-156, 1996.","DOI":"10.1016\/S0046-8177(96)90368-8"},{"key":"14","unstructured":"14. Shuin T, Yamasaki I, Tamura K, Okuda H, Furihata M, Ashida S. Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Jpn J Clin Oncol 36: 337-343, 2006."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet 361: 2059-2067, 2003.","DOI":"10.1016\/S0140-6736(03)13643-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kuwai T, Kiadai Y, Tanaka S, et al. Expression of hypoxia-inducible factor-1α is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105: 176-181, 2003.","DOI":"10.1002\/ijc.11068"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Xue X, Taylor M, Anderson E, et al. HIF-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis. Cancer Res 72: 2285-2293, 2012.","DOI":"10.1158\/0008-5472.CAN-11-3836"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61, 1989.","DOI":"10.1038\/339058a0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Cockman ME, Masson N, Mole DR, et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275: 25733-25741, 2000.","DOI":"10.1074\/jbc.M002740200"},{"key":"20","unstructured":"20. Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292: 464-468, 2001."},{"key":"21","unstructured":"21. Los M, Jansen GH, Kaelin WG, Lips CJ, Blijham GH, Voest EE. Expression pattern of the von Hippel-Lindau protein in human tissues. Lab Invest 75: 231-238, 1996."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Giles RH, Lolkema MP, Snijckers CM, et al. Interplay between VHL\/HIF1alpha and Wnt\/beta-catenin pathways during colorectal tumorigenesis. Oncogene 25: 3065-3070, 2006.","DOI":"10.1038\/sj.onc.1209330"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/14\/52_52.8278\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:48:11Z","timestamp":1621446491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/14\/52_52.8278\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":22,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.8278","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}